Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kavanagh

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Urologic Oncology|December 25, 2015
Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data BaseArya Amini, Chad G Rusthoven, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data BaseArya Amini, Bernard L Jones, Norman Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenationBrian D Kavanagh, Timothy W Secomb, Richard Hsu, et al.
Health Services Research|September 1, 2017
Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?Aileen B Chen, Ling Li, Angel M Cronin, et al.
Urologic Oncology|August 25, 2014
Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancerChad G Rusthoven, Timothy V Waxweiler, Peter E DeWitt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastasesTracey E Schefter, Brian D Kavanagh, Robert D Timmerman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasisJoseph M Baisden, Andrew G Reish, Ke Sheng, et al.
Clinical Lung Cancer|July 11, 2021
Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on PralsetinibDavid Chun Cheong Tsui, Brian D Kavanagh, Justin M Honce, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2009
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysisKyle E Rusthoven, Susan F Hammerman, Brian D Kavanagh, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Urologic Oncology|December 25, 2015
Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data BaseArya Amini, Chad G Rusthoven, Bernard L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation TherapyColton J Ladbury, Chad G Rusthoven, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data BaseArya Amini, Bernard L Jones, Norman Yeh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenationBrian D Kavanagh, Timothy W Secomb, Richard Hsu, et al.
Health Services Research|September 1, 2017
Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?Aileen B Chen, Ling Li, Angel M Cronin, et al.
Urologic Oncology|August 25, 2014
Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancerChad G Rusthoven, Timothy V Waxweiler, Peter E DeWitt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastasesTracey E Schefter, Brian D Kavanagh, Robert D Timmerman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasisJoseph M Baisden, Andrew G Reish, Ke Sheng, et al.
Clinical Lung Cancer|July 11, 2021
Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on PralsetinibDavid Chun Cheong Tsui, Brian D Kavanagh, Justin M Honce, et al.
Acta Oncologica (Stockholm, Sweden)|April 18, 2009
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysisKyle E Rusthoven, Susan F Hammerman, Brian D Kavanagh, et al.
Pageof 15